MAJOR DETERMINANTS OF EUROQOL (EQ-5D) IN PATIENTS WITH RHEUMATOID ARTHRITIS BASED ON A LARGE JAPANESE COHORT IORRA

Author(s)

Ataru Igarashi, PhD, Assitant Professor1, Daisuke Hoshi, MD, @2, Shinya Orihara, BS, Graduate student1, Eisuke Inoue, MPH, -2, Shigeki Momohara, MD, PhD, Professor2, Masako Hara, MD, PhD, Professor2, Naoyuki Kamatani, MD, PhD, Professor2, Hisashi Yamanaka, MD, PhD, Professor2, Kiichiro Tsutani, MD, PhD, Professor11The University of Tokyo, Bunkyo, Tokyo, Japan; 2 Tokyo women's medical university, Shinjyuku, Tokyo, Japan

OBJECTIVES: To maintain good quality of life (QOL) is an important goal in the management of patients with rheumatoid arthritis (RA). Since QOL of RA patients is influenced by many factors, we quantitatively measured QOL of RA patients based on Japanese version of EuroQoL (EQ-5D), and we analyzed the major determinants of EQ-5D in RA patients using a large observational cohort of RA patients in Japan. METHODS: IORRA (Institute Of Rheumatology Rheumatoid Arthritis) is an observational cohort of RA patients established in the Institute of Rheumatology Tokyo Women's Medical University since 2000. Essentially all RA patients who consulted there were registered, and clinical parameters including the disease activity, use of drugs and the occurrence of adverse events in daily clinical settings were assessed biannually based on patient's report, physician's examination and laboratory data. In this cohort, we evaluated QOL of RA patients using EQ-5D, and then analyzed the factors that influenced on EQ-5D by the analysis of variance. The factors analyzed here were gender, age, disease duration, disease activity, disability, and comorbidity. RESULTS: In September 2007, a total 5,023 RA patients (female 84.2%, average 58.0 years-old, average disease duration 11.3 years, rheumatoid factor positive 74.8%, patients taking steroid, methotrexate and biologics were 51.0%, 63.6%, and 4.3%, respectively) answered the questionnaire of EQ-5D. The factors aand the percentage of their contributions on EQ-5D were as follows; i) disability assessed by JHAQ (Japanese Health Assessment Questionnaire): 57.6%, pain VAS (visual analog scale): 12.5%, female: 6.1%, joint surgery: 5.9%, non-orthopedic surgery: 5.4%, duration of disease: 1.8% and occurrence of fractures: 1.3%. CONCLUSIONS: QOL of RA patients is deeply influenced by the disability together with comorbidity. Management for the control of both disease activity and comorbidity is crucial.

Conference/Value in Health Info

2008-11, ISPOR Europe 2008, Athens, Greece

Value in Health, Vol. 11, No. 6 (November 2008)

Code

PMS51

Topic

Patient-Centered Research

Topic Subcategory

Patient-reported Outcomes & Quality of Life Outcomes

Disease

Musculoskeletal Disorders

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×